Search

everythinglearnresearchcommunity

for

Search:↓

The oral supplement improved hair loss in patients with telogen effluvium.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

People with Collagen VI-related myopathies may often have hair loss and scalp issues.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Deep Brain Stimulation helps manage Parkinson's symptoms when medication isn't enough.

Mother-in-law's tongue leaf extract at 20% concentration significantly promotes hair growth in male rabbits.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

Certain polyphenols may help treat skin pigmentation disorders.

Cancer patients with COVID-19 face higher risks due to possible additional infections.

An 8-year-old boy with hair loss had hair regrowth and responded well to clobetasol propionate treatment.

A 1-year-old boy developed excessive hair growth from exposure to a hair growth treatment.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Nellore cattle have genetic variations linked to their adaptation to tropical environments.

A stray cat with severe scabies recovered after 4 weeks of treatment.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Understanding and treating alopecia areata improves patient care.

The guidelines suggest reconsidering PCOS criteria for better diagnosis and care.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Women with PCOS have more severe liver disease.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.